BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,233,796 | +64.2% | 602,027 | +106.6% | 0.35% | +62.4% |
| Q2 2023 | $18,414,078 | +288.4% | 291,362 | +176.5% | 0.22% | +240.6% |
| Q1 2023 | $4,740,911 | -55.0% | 105,377 | -56.2% | 0.06% | -54.6% |
| Q4 2022 | $10,544,804 | +71.4% | 240,694 | +157.7% | 0.14% | +64.0% |
| Q3 2022 | $6,153,000 | +4.9% | 93,387 | -19.6% | 0.09% | -4.4% |
| Q2 2022 | $5,864,000 | +269.0% | 116,087 | +366.7% | 0.09% | +246.2% |
| Q1 2022 | $1,589,000 | -76.1% | 24,873 | -59.9% | 0.03% | -72.6% |
| Q4 2021 | $6,647,000 | -62.4% | 62,055 | -63.9% | 0.10% | -67.1% |
| Q3 2021 | $17,687,000 | +252.4% | 172,035 | +201.5% | 0.29% | +207.4% |
| Q2 2021 | $5,019,000 | -41.9% | 57,056 | -35.8% | 0.09% | -51.0% |
| Q1 2021 | $8,644,000 | – | 88,906 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |